Lets understand What is Brachytherapy? Brachytherapy is an advanced form of cancer treatment that delivers radiation directly inside or very close to the tumour. It is widely used in the UK for treating prostate cancer, offering a highly targeted approach that minimises damage to surrounding healthy tissues.
Introduction Prostate cancer is one of the most common cancers among men worldwide. Accurate diagnosis depends on prostate biopsy procedures that allow clinicians to collect tissue samples for histopathological analysis. Hospitals are rapidly shifting from the traditional transrectal (TR) to the transperineal (TP) biopsy for prostate cancer diagnosis primarily because the TP approach eliminates the risk of serious infection/sepsis by avoiding the needle passage through the rectum. This shift is fueled by increasing antibiotic resistance in rectal flora and improved technology that allows TP biopsy to be performed in an office setting under local anesthesia. For decades, the transrectal ultrasound-guided prostate biopsy was the most widely used technique. However, growing concerns regarding infection risk, diagnostic limitations, and healthcare costs have prompted hospitals to reconsider their biopsy pathways. Lets understand why are hospitals moving to Transperineal Prostate Biopsy. What are the challenges faced by hospitals? Hospitals using the traditional transrectal biopsy method face several clinical and operational challenges. 1. Infection and Sepsis Risk Transrectal biopsy involves passing a biopsy needle through the rectal wall, exposing patients to bacteria present in the rectum. Studies show that this approach can lead to urinary tract infections, prostatitis, and sepsis in some patients. Infection rates following transrectal biopsy have been reported as high as 5–7% in some cases, even when antibiotic prophylaxis is used. Sepsis rates following TR biopsy have been reported between 0.4% and 9.8%, making infection one of the most significant complications of the procedure. These complications increase hospital admissions, antibiotic usage, and healthcare costs. 2. Limited access to certain areas of the Prostate Another limitation of the transrectal approach is the difficulty in accessing the anterior region of the prostate. Missing these lesions can delay diagnosis and treatment. Studies indicate that transrectal biopsy can miss cancers located in these areas, with approximately 10% of prostate cancers occurring exclusively in the anterior prostate. 3. Rising healthcare costs Post-biopsy infections can lead to: These complications significantly increase the cost burden for healthcare systems. Shift towards Transperineal Biopsy To address the above mentioned challenges, hospitals have increasingly adopted the transperineal biopsy technique. Instead of passing through the rectum, the biopsy needle is inserted through the perineum, allowing direct access to the prostate while avoiding rectal bacteria. This change in approach has demonstrated several clinical and operational advantages. What are the clinical benefits of Transperineal Biopsy? Transperineal prostate biopsy is increasingly preferred over the traditional transrectal approach because it offers better diagnostic accuracy and improved patient safety. Below are the main clinical benefits of transperineal biopsy. Some of the clinical benefits of Transperineal Biopsy are as follows. 1. Significantly lower Infection Risk One of the most important advantages of the transperineal approach is its reduced infection risk. Research shows that transperineal biopsy is associated with up to 77% lower risk of hospitalisation due to infectious complications compared with transrectal biopsy. Some studies report infection rates below 1% and sepsis rates under 0.5% following transperineal biopsy. In clinical trials, patients undergoing transperineal biopsy experienced zero infections, while infections were observed in the transrectal group. Because the needle does not pass through the rectum, exposure to bacteria is greatly reduced. 2. Improved Cancer Detection The transperineal approach allows clinicians to sample all regions of the prostate, including the anterior and apical zones that are difficult to reach via the transrectal route. This improves diagnostic accuracy and helps clinicians detect clinically significant prostate cancers earlier. Studies also indicate that the cancer detection rate is comparable or slightly better than the traditional approach. 3. Reduced Antibiotic Dependence Because the infection risk is much lower, transperineal biopsy can often be performed without prophylactic antibiotics, reducing antibiotic resistance concerns. This is particularly important in modern healthcare systems that are trying to reduce unnecessary antibiotic use. What are the operational benefits for hospitals? Beyond clinical advantages, the transperineal approach also improves operational efficiency. 1. Standardised Biopsy Workflow Modern transperineal systems use grid-based or freehand guidance devices, allowing clinicians to perform systematic sampling with greater precision. 2. Day Case Procedure The procedure can often be performed under local anaesthesia, enabling same-day discharge for most patients. 3. Reduced Complication Costs Lower infection rates reduce: This makes the procedure more cost-effective for healthcare providers. Case Example: Hospital Implementation Hospital Profile Previous Method Transrectal ultrasound guided biopsy and the challenges includes: Implementation The hospital transitioned to transperineal ultrasound-guided biopsy using a stepper stabiliser and biopsy grid system. Let’s analyze the results after implementation. Metric Before (TR) After (TP) Infection Rate ~2–3% <1% Sepsis Cases Occasional Rare Anterior Cancer Detection Limited Improved Hospital Admissions Higher Reduced Antibiotic Use Required Minimal What are the economic impacts of Transperineal Biopsy? International clinical guidelines are increasingly supporting the transperineal approach. Lower infection rates significantly reduced hospital costs associated with post-biopsy complications. In addition, streamlined biopsy workflows allowed the department to increase procedural capacity. For example, European urology guidelines recommend transperineal biopsy as a preferred method due to its lower risk of infectious complications. Similarly, health technology assessments have concluded that transperineal biopsy systems can be cost-effective options for diagnosing prostate cancer. Conclusion The transition from transrectal to transperineal prostate biopsy represents a significant advancement in prostate cancer diagnostics. Hospitals are adopting this approach because it offers: As clinical evidence continues to grow, the transperineal biopsy technique is rapidly becoming the preferred standard for prostate biopsy procedures worldwide.
Testicular lumps can occur in men of any age, but they are most commonly detected in men between 15 and 45 years old. While some lumps are harmless and caused by conditions such as cysts, fluid buildup, or infections, others may be an early sign of testicular cancer, which is highly treatable when detected early. Learn more.
Nocturia is a condition where you wake up multiple times during the night to urinate. It can result from excessive fluid intake, sleep disturbances, or blockage in the urinary tract. Management may involve limiting evening fluids and using medications that help control overactive bladder symptoms. Learn more.
Urinary tract infections can affect men, though they are far less common than in women. Learn more.
Chronic pelvic pain is long-lasting discomfort in the lower abdomen or pelvis. It occurs below the belly button and between the hips. The pain usually lasts six months or longer. It can have many possible causes. Sometimes it is linked to another medical condition. In other cases, no clear cause is found. Learn more..
Cystoscopy is a procedure to check what’s causing bladder symptoms, treat bladder conditions and to diagnose and treat bladder cancer. Learn What is Cystoscopy.
Here’s some genuinely good news for men. Enjoying a more active sex life, including regular masturbation, may actually help protect your prostate. As researchers continue to explore whether sex and masturbation affect prostate cancer, studies suggest that frequent ejaculation is linked to a lower risk of prostate cancer. Learn more.
When people hear the term prostate cancer, it is almost always associated with men, largely because the prostate is traditionally considered a male reproductive organ. This often leads to the common question, “Do women have a prostate” Growing medical awareness shows that, in rare cases, prostate-like cancer can occur in women as well. This article will explain the female prostate cancer symptoms. Let’s go through it in detail. What are female prostate cancer symptoms? Here are five important female prostate cancer symptoms Can women have prostate cancer? Prostate cancer in women is exceptionally uncommon. Because it is not widely discussed, early recognition and diagnosis can be difficult. This leads many to ask, can women get a prostate cancer? However, understanding that such a condition can exist is an important step toward awareness. Understanding the anatomy involved helps women and healthcare professionals recognise unusual symptoms early. Increased awareness supports earlier recognition of potential concerns. This allows timely medical evaluation and appropriate follow-up when needed. Although women do not have a prostate like men, they have small Skene’s glands near the urethra. They develop from the same embryonic tissue as the male prostate. Because of their functional similarities, they are sometimes called the “female prostate.” On rare occasions, these glands can develop abnormal cellular changes, including cancer. What signs can we see of prostate cancer in women? Identifying the signs of prostate cancer in women can be difficult because the condition is rare. Some common warning signs include: These signs in women are not specific to cancer and may be caused by other conditions. Seeking medical advice is important to determine the cause and ensure proper treatment. What are the screening tests for prostate cancer? Although prostate cancer primarily affects men, understanding how it affects females remains important. Women with Skene’s gland cancer can experience symptoms similar to prostate conditions, such as pain during urination or sexual activity. Early evaluation and consultation with a urologist support timely diagnosis and appropriate treatment. Diagnosing Prostate Cancer in Women Early and precise diagnosis is vital. The evaluation process usually includes: These diagnostic steps are important for distinguishing cancer from other conditions that may cause similar symptoms. Causes and risks of Prostate Cancer in Women Understanding the possible causes of prostate cancer in women is important for awareness and prevention. Although the exact cause is not fully known, certain factors may increase the risk, including: While these factors do not necessarily lead to cancer, awareness of them can help women make informed decisions about their health. Preventive Measures for Prostate Cancer in Women Prevention is important in lowering the risk of prostate cancer in women. The following practical steps can help: Focusing on preventive care supports long-term health and well-being. Treatment for Prostate Cancer in Women If prostate cancer is diagnosed, treatment options vary based on the stage of the cancer and its severity. Common approaches include: Consulting helps ensure a personalised treatment plan. Clear and open communication with your doctor is essential for understanding available options and making informed decisions. Conclusion Although prostate cancer in women is rare, understanding its symptoms is essential. Awareness, early recognition, and prompt medical evaluation can significantly improve outcomes. If you notice concerning signs or have ongoing symptoms, seeking advice from a qualified healthcare professional can help ensure timely diagnosis and appropriate care. If you’ve been asking, What are female prostate cancer symptoms? Detecting early remains essential for effective care. Do not delay in reaching out to a healthcare professional for evaluation. FAQs
Many people assume prostate cancer affects only cisgender men, but trans women also have a prostate unless it has been surgically removed, which is rare. Because of this, Do Trans Women have a Prostate is an important topic to understand the connection between trans women and prostate cancer, how it works, how transition affects prostate health, and what symptoms to look out for. Learn More.